期刊文献+

三种子宫内膜准备方案胚胎移植日血清雌孕激素水平、胚胎种植率、临床妊娠率的比较研究 被引量:1

三种子宫内膜准备方案胚胎移植日血清雌孕激素水平、胚胎种植率、临床妊娠率的比较研究
下载PDF
导出
摘要 目的探讨超排卵(Super-ovulation)控制性超排卵(controlled ovarian hyperstimulation,COH)和雌孕激素替代治疗(hormone replacement treatment,HRT)三种子宫内膜准备方案对胚胎移植日血清雌孕激素水平、人胚胎种植率及临床妊娠率的影响。方法2004年1月至2005年10月在我中心采用不同治疗方案行IVF-ET的不孕妇女分为3组:超排卵组、控制性超排卵组和雌孕激素替代治疗组。体外受精-胚胎移植按我中心常规方法进行。酶联免疫吸附双抗夹心法(ELASA)检测ET日血清雌孕激素水平。各组IVF ET的实验室和临床资料进行分析比较。结果同期COH组超排卵药物总剂量和获卵数分别为(30.12±10.18)支和(10.35±2.01)个,明显高于超排卵组(8.21±4.19)支和(5.05±3.11)个(P<0.05);COH组胚胎种植率和临床妊娠率分别为21.19%和34.55%,明显低于HRT组(34.9,52.38%)和超排卵组(32.43%,50%)(P<0.05)。COH组ET日E_2水平(825.24±558.95 pg/mL),明显高于超排卵组(395.8±287.27pg/mL)及HRT组(407.72±123.76pg/mL)(P<0.05)。COH组P水平(109.31±82.61 ng/mL)明显高于HRT组(62.63±31.54 ng/mL)(P<0.05),而与超排卯组比较无明显差异(P>0.05)。COH组E_2/P比值(8.34±1.76)明显高于超排卵组(4.51±2.32)及HRT组(5.96±3.87)(P<0.05)。结论COH组胚胎种植率和临床妊娠率低于HRT组和超排卵组。COH组超生理的雌激素水平可能影响人胚胎种植率和临床妊娠率。 Objective To evaluate effects on the level of E2, P in blood serum ,human implantation rate and clinical pregnancy rate based on different protocols. Methods From January 2004 to August 2005, patients undergoing treatment for IVF-ET were recruited from the reproductive center of The First Affiliated Hospital of Zheng Zhou University. According to the treatment protocols, the recruited patients were divided into 3 groups: Superovulation group, COH group , HRT group .The method of IVF ET was done in a routine way in our center. The enzyme linked immunosorbent assay (ELISA) is used to quantify E2 and P in blood serum on embryo transfer day. The laboratory data and clinical material of IVF-ET were collected and analysed. Results The amounts of gonadotropin (Gn) and the oocytes number in COH group are (30.12 ± 10.18), (10.35 ±2.01), significantly higher than that in superovulation group (8.21 ± 4.19), (5.05 ± 3.11)(P 〈 0.05). The implantation rate and clinical pregnancy rate in COH group are 21.19%,34.55%, significantly lower than that in HRT group (34.9,52.38%) and superovulation group (32.43%,50%) (P〈 0.05). The E2 level in blood serum on ET day of COH group is (825.24 ± 558.95) pg/ml, significantly higher than that in superovulation group and HRT group (395.8 ±287.27) pg/mL, (407.7± 123.76) pg/mL (P〈 0.05). The level of P (109.31 ± 82.61 ng/mL) of COH group is significantly higher than that in HRT group (62.63 ± 31.54 ng/ ml) (P 〈0.05). The ratio of E2/P in COH group (8.34 ± 1.76) is significantly higher than that in superovulation group (4. 51 ± 2.32)and H RT group (5.96 ± 3.87)(P 〈 0.05). Conclusion The implantation rate and clinical pregnancy rate in C OH group is significantly lower than that in superovulation group and HRT group.High concentrations of E2 caused by ovarian stimulation may affect the human implantation rate and clinical pregnancy rate.
出处 《中国医药指南(学术版)》 2008年第7期1-4,共4页 Guide of China Medicine
基金 河南省医学科技创新人才工程项目项目编号:20060046
关键词 17Β雌二醇 体外受精-胚胎移植 控制性超排卵 激素替代治疗 卵巢早衰 17 β estradiol In vitro fertilization-embryo transfer Controlled ovarian hyperstimulation Hormone replacement treatment Premature ovarian failure
  • 相关文献

参考文献6

二级参考文献32

  • 1孙莹璞,徐瑜,苏迎春,朱桂金,郭艺红.人胚胎透明带厚度及其变量与体外受精-胚胎移植妊娠结局的关系[J].生殖医学杂志,2004,13(6):349-353. 被引量:47
  • 2徐庆中,段会玲,卢德宏,杨虹.星形细胞瘤的胶质纤维酸性蛋白和波形蛋白免疫组织化学定量研究[J].中华病理学杂志,1994,23(2):66-68. 被引量:21
  • 3黄荷凤,石一复,周馥贞,杨树标,何柏松.醋酸亮丙瑞林辅助排卵对雌二醇和子宫内膜分泌功能的影响[J].中华妇产科杂志,1996,31(2):103-106. 被引量:4
  • 4黄荷凤,中华妇产科杂志,1996年,31卷,103页
  • 5Dewailly D. Definition and significance ofpolycystic ovaries.Baillieres Clin Obstet Gynaecol, 1997, 11(2):349-68.
  • 6Rizk B &amp; Aboulghar MA. Classification, pathophysiology and management of ovarian hyperstimulation syndrome. In:Peeter R Brinsden,ed. A Textbook of In vitro Fertilization and Assisted Reproduction. London: Parthenon Publishing Group, 1999, p.131.
  • 7Ozornek MH, Bielfeld P, Krussel JS, et al. Epidermal growth factor and leukaemia inhibitory factor levels in follicular fluid.Association with in vitro fertilization outcome. J Reprod Med, 1999, 44(4): 367-9.
  • 8Arici A, Oral E, Bahtiyar O, et al. Leukaemia inhibitory factor expression in human follicular fluid and ovarian cells.Hum Reprod, 1997, 12(6): 1 233-9.
  • 9Ledee-Bataille N, Lapree-Delage G, Taupin JL, et al. Follicular fluid concentration of leukaemia inhibitory factor is decreased among women with polycystic ovarian syndrome during assisted reproduction cycles. Hum Reprod, 2001,16(10): 2 073-8.
  • 10Lavranos TC, Rathjen PD &amp; Seamark RF. Tropic effects of myeloid leukaemia inhibitory factor (LIF) on mouse embryos.J Reprod Fertil, 1995, 105(2): 331-8.

共引文献43

同被引文献12

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部